Showing results (11-20 of 3,435) with videos related to
Sort By:
Pageof 344
Nature Reviews. Clinical Oncology|February 15, 2017
The changing landscape of clinical trial and approval processes in ChinaQing Zhou, Xiao-Yuan Chen, Zhi-Min Yang, et al.Frontiers in Oncology|April 1, 2022
Applications of Circulating Tumor DNA in Immune Checkpoint Inhibition: Emerging Roles and Future PerspectivesChang Lu, Yi-Chen Zhang, Zhi-Hong Chen, et al.Immunological Investigations|October 9, 2009
An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancerKun Wang, Qing Zhou, Ai-Lin Guo, et al.Onkologie|April 18, 2008
EGFR/KRAS mutations and gefitinib therapy in Chinese NSCLC patientsZhen Wang, Yi Long Wu, Guo Chun Zhang, et al.Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|August 2, 2007
[Association of XAGE-1b gene expression with clinical characteristics of non-small cell lung cancer]Qing Zhou, Ai-lin Guo, She-juan An, et al.Clinical Lung Cancer|June 2, 2022
Safety and Efficacy of Epitinib for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases: Open-Label Multicentre Dose-Expansion Phase Ib StudyQing Zhou, Mengzhao Wang, Helong Zhang, et al.Thoracic Cancer|November 2, 2016
Heterogeneity of the resistance to gefitinib treatment in a non-small cell lung cancer patient with active epidermal growth factor receptor mutationChong-Rui Xu, Wen-Zhao Zhong, Qing Zhou, et al.Thoracic Cancer|April 16, 2020
Mutational landscape and characteristics of ERBB2 in non-small cell lung cancerXue-Wu Wei, Xin Gao, Xu-Chao Zhang, et al.BMC Cancer|September 21, 2014
A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lungJin-Ji Yang, Cheng Huang, Gong-Yan Chen, et al.Journal of Hematology & Oncology|August 9, 2017
Clinical trials of tyrosine kinase inhibitors for lung cancer in China: a reviewShan Su, Yi-Long WuPageof 344